-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Nevro, Raises Price Target to $5.85

Benzinga·02/07/2025 18:58:05
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Nevro (NYSE:NVRO) with a Hold and raises the price target from $4 to $5.85.